J. Drabo

Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial

Laura Ciaffi, Sinata Koulla‐Shiro, Adrien Sawadogo et al. · The Lancet HIV · 2017 · 72 citations

Public Health, Community Health, Pharmacotherapy +17

[Prevalence and factors associated with low back pain among hospital staff in Ouagadougou (Burkina Faso)].

Dieu‐Donné Ouedraogo, Victor Pingdéwendé Ouédraogo, Leopold Ouédraogo et al. · PubMed · 2010 · 19 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +7

[Prevalence and risk factors associated with infection by human immunodeficiency virus, hepatitis B virus, syphilis and bacillary pulmonary tuberculosis in prisons in Burkina Faso].

Éric Arnaud Diendéré, Hervé Tiéno, Réné Bognounou et al. · PubMed · 2011 · 19 citations

Public Health, Immunology, Infectious Diseases +15

Impact of a modified directly administered antiretroviral treatment intervention on virological outcome in HIV‐infected patients treated in Burkina Faso and Mali

CM Pirkle, Cathérine Boileau, V‐K Nguyen et al. · HIV Medicine · 2009 · 17 citations

Public Health, Pharmacotherapy, Hiv Control +15

Connective tissue diseases in hospital practice in Ouagadougou (Burkina Faso)

Dieu‐Donné Ouedraogo, N. Korsaga-Somé, J. Zabsonné Tiendrébéogo et al. · Médecine et Santé Tropicales · 2014 · 14 citations

Medicine, Dermatology, Immunology +15